Ben Hargreaves discovers how research has emerged outlining how the gut microbiome plays a crucial role in patients’ response ...
In yesterday’s exchange of views, Amgen sought to convince SCOTUS that its core or “genus” patent on blockbuster PCSK9 ...
Lipoprotein(a) is well established as a risk factor for cardiovascular disease, but patients rarely get tested for it. Now, ...
Jounce has instead thrown its lot in with Concentra Biosciences, another US company that emerged to woo Jounce with an ...
The FDA has laid out its thinking on the design of clinical trials used to support filings for accelerated approval of cancer ...
The ramped-up investment – taking the total spend to almost $1 billion – is destined for a new unit at a greenfield site in Limerick that, according to the pharma company, will become its most ...
Healthware Group has released the expert opinion report, ‘Digital therapeutics to enhance the care pathways for depression across the national health service: expert proposals for Italy’. The document ...
Between all this, one team has been bearing the badge of agility and dynamism: yes, the business strategy and forecasting ...
On March 28th and 29th, industry leaders from across the pharmaceutical ecosystem will descend on Philadelphia for Reuters ...
Dutch biotech Pharming has claimed FDA approval for Joenja, the first drug indicated for recently identified rare ...
The causes of CKD are manifold, and include recurrent infection, various forms of nephritis, or other conditions, such as ...
Better Therapeutics has become the latest company in the digital health sector to announce big job cuts, saying it needs to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results